 | • レポートコード：20QY06-04761 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、加齢黄斑変性薬のグローバル市場について種類別（ルセンティス、アイリーア、アバスチン、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・加齢黄斑変性薬市場の概要 ・世界の主要地域別加齢黄斑変性薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の加齢黄斑変性薬市場規模2015-2026：種類別（ルセンティス、アイリーア、アバスチン、その他） ・世界の加齢黄斑変性薬市場規模2015-2026：用途別（病院、クリニック、その他） ・加齢黄斑変性薬の北米市場規模2015-2020 ・加齢黄斑変性薬のヨーロッパ市場規模2015-2020 ・加齢黄斑変性薬の中国市場規模2015-2020 ・加齢黄斑変性薬の日本市場規模2015-2020 ・加齢黄斑変性薬の東南アジア市場規模2015-2020 ・加齢黄斑変性薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Regeneron Pharmaceuticals、Bayer HealthCare、Novartis、Roche、Kanghong Pharma） ・加齢黄斑変性薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・加齢黄斑変性薬の市場動向・機会・課題 ・調査の結論 |
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
Age Related Macular Degeneration Drug is widely used in hospitals, clinics and other field. The most proportion of Age Related Macular Degeneration Drug is used in Hospital, and the proportion in 2017 is 72%.
Market Analysis and Insights: Global Age Related Macular Degeneration Drug Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Age Related Macular Degeneration Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Age Related Macular Degeneration Drug industry.
Based on our recent survey, we have several different scenarios about the Age Related Macular Degeneration Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 6857.2 million in 2019. The market size of Age Related Macular Degeneration Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Age Related Macular Degeneration Drug Scope and Market Size
The global Age Related Macular Degeneration Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Age Related Macular Degeneration Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Age Related Macular Degeneration Drug market is segmented into
Lucentis
Eylea
Avastin
Other
Segment by Application, the Age Related Macular Degeneration Drug market is segmented into
Hospitals
Clinics
Other
The Age Related Macular Degeneration Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Age Related Macular Degeneration Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Age Related Macular Degeneration Drug Market Share Analysis
Age Related Macular Degeneration Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Age Related Macular Degeneration Drug business, the date to enter into the Age Related Macular Degeneration Drug market, Age Related Macular Degeneration Drug product introduction, recent developments, etc.
The major vendors covered:
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
…
1 Age Related Macular Degeneration Drug Market Overview
1.1 Age Related Macular Degeneration Drug Product Scope
1.2 Age Related Macular Degeneration Drug Segment by Type
1.2.1 Global Age Related Macular Degeneration Drug Sales by Type (2020-2026)
1.2.2 Lucentis
1.2.3 Eylea
1.2.4 Avastin
1.2.5 Other
1.3 Age Related Macular Degeneration Drug Segment by Application
1.3.1 Global Age Related Macular Degeneration Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Age Related Macular Degeneration Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Age Related Macular Degeneration Drug Sales Growth Rate (2015-2026)
1.4.2 Global Age Related Macular Degeneration Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Age Related Macular Degeneration Drug Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Age Related Macular Degeneration Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Age Related Macular Degeneration Drug Industry
1.5.1.1 Age Related Macular Degeneration Drug Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Age Related Macular Degeneration Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Age Related Macular Degeneration Drug Players to Combat Covid-19 Impact
2 Age Related Macular Degeneration Drug Estimate and Forecast by Region
2.1 Global Age Related Macular Degeneration Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Age Related Macular Degeneration Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Age Related Macular Degeneration Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Region (2015-2020)
2.3 Global Age Related Macular Degeneration Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Age Related Macular Degeneration Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Age Related Macular Degeneration Drug Estimates and Projections (2015-2026)
2.4.2 Europe Age Related Macular Degeneration Drug Estimates and Projections (2015-2026)
2.4.3 China Age Related Macular Degeneration Drug Estimates and Projections (2015-2026)
2.4.4 Japan Age Related Macular Degeneration Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Age Related Macular Degeneration Drug Estimates and Projections (2015-2026)
2.4.6 India Age Related Macular Degeneration Drug Estimates and Projections (2015-2026)
3 Global Age Related Macular Degeneration Drug Competition Landscape by Players
3.1 Global Top Age Related Macular Degeneration Drug Players by Sales (2015-2020)
3.2 Global Top Age Related Macular Degeneration Drug Players by Revenue (2015-2020)
3.3 Global Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age Related Macular Degeneration Drug as of 2019)
3.4 Global Age Related Macular Degeneration Drug Average Price by Company (2015-2020)
3.5 Manufacturers Age Related Macular Degeneration Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Age Related Macular Degeneration Drug Players (Opinion Leaders)
4 Global Age Related Macular Degeneration Drug Market Size by Type
4.1 Global Age Related Macular Degeneration Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Age Related Macular Degeneration Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Age Related Macular Degeneration Drug Price by Type (2014-2020)
4.2 Global Age Related Macular Degeneration Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Age Related Macular Degeneration Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Age Related Macular Degeneration Drug Price Forecast by Type (2021-2026)
5 Global Age Related Macular Degeneration Drug Market Size by Application
5.1 Global Age Related Macular Degeneration Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Age Related Macular Degeneration Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Age Related Macular Degeneration Drug Price by Application (2015-2020)
5.2 Global Age Related Macular Degeneration Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Age Related Macular Degeneration Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Age Related Macular Degeneration Drug Price Forecast by Application (2021-2026)
3 North America Age Related Macular Degeneration Drug Market Facts & Figures
3.2 North America Age Related Macular Degeneration Drug Sales Market Share by Company (2015-2020)
3.3 North America Age Related Macular Degeneration Drug Sales Market Share by Type (2015-2020)
3.4 North America Age Related Macular Degeneration Drug Sales Market Share by Application (2015-2020)
4 Europe Age Related Macular Degeneration Drug Market Facts & Figures
4.2 Europe Age Related Macular Degeneration Drug Sales Market Share by Company (2015-2020)
4.3 Europe Age Related Macular Degeneration Drug Sales Market Share by Type (2015-2020)
4.4 Europe Age Related Macular Degeneration Drug Sales Market Share by Application (2015-2020)
5 China Age Related Macular Degeneration Drug Market Facts & Figures
5.2 China Age Related Macular Degeneration Drug Sales Market Share by Company (2015-2020)
5.3 China Age Related Macular Degeneration Drug Sales Market Share by Type (2015-2020)
5.4 China Age Related Macular Degeneration Drug Sales Market Share by Application (2015-2020)
6 Japan Age Related Macular Degeneration Drug Market Facts & Figures
6.2 Japan Age Related Macular Degeneration Drug Sales Market Share by Company (2015-2020)
6.3 Japan Age Related Macular Degeneration Drug Sales Market Share by Type (2015-2020)
6.4 Japan Age Related Macular Degeneration Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Age Related Macular Degeneration Drug Market Facts & Figures
7.2 Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Application (2015-2020)
8 India Age Related Macular Degeneration Drug Market Facts & Figures
8.2 India Age Related Macular Degeneration Drug Sales Market Share by Company (2015-2020)
8.3 India Age Related Macular Degeneration Drug Sales Market Share by Type (2015-2020)
8.4 India Age Related Macular Degeneration Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Age Related Macular Degeneration Drug Business
12.1 Regeneron Pharmaceuticals
12.1.1 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Corporation Information
12.1.2 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Business Overview and Total Revenue
12.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Products Offered
12.1.5 Regeneron Pharmaceuticals Recent Development
12.2 Bayer HealthCare
12.2.1 Bayer HealthCare Age Related Macular Degeneration Drug Corporation Information
12.2.2 Bayer HealthCare Age Related Macular Degeneration Drug Business Overview and Total Revenue
12.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer HealthCare Age Related Macular Degeneration Drug Products Offered
12.2.5 Bayer HealthCare Recent Development
12.3 Novartis
12.3.1 Novartis Age Related Macular Degeneration Drug Corporation Information
12.3.2 Novartis Age Related Macular Degeneration Drug Business Overview and Total Revenue
12.3.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Age Related Macular Degeneration Drug Products Offered
12.3.5 Novartis Recent Development
12.4 Roche
12.4.1 Roche Age Related Macular Degeneration Drug Corporation Information
12.4.2 Roche Age Related Macular Degeneration Drug Business Overview and Total Revenue
12.4.3 Roche Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Roche Age Related Macular Degeneration Drug Products Offered
12.4.5 Roche Recent Development
12.5 Kanghong Pharma
12.5.1 Kanghong Pharma Age Related Macular Degeneration Drug Corporation Information
12.5.2 Kanghong Pharma Age Related Macular Degeneration Drug Business Overview and Total Revenue
12.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Kanghong Pharma Age Related Macular Degeneration Drug Products Offered
12.5.5 Kanghong Pharma Recent Development
…
13 Age Related Macular Degeneration Drug Manufacturing Cost Analysis
13.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug
13.4 Age Related Macular Degeneration Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Age Related Macular Degeneration Drug Distributors List
14.3 Age Related Macular Degeneration Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Age Related Macular Degeneration Drug Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Age Related Macular Degeneration Drug Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Age Related Macular Degeneration Drug Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Age Related Macular Degeneration Drug Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Age Related Macular Degeneration Drug Players to Combat Covid-19 Impact
Table 8. Global Market Age Related Macular Degeneration Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Age Related Macular Degeneration Drug Sales (K Units) by Region (2015-2020)
Table 10. Global Age Related Macular Degeneration Drug Sales Market Share by Region (2015-2020)
Table 11. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Age Related Macular Degeneration Drug Revenue Share by Region (2015-2020)
Table 13. Global Age Related Macular Degeneration Drug Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Age Related Macular Degeneration Drug Revenue Share Forecast by Region (2021-2026)
Table 17. Global Age Related Macular Degeneration Drug (K Units) of Key Companies (2015-2020)
Table 18. Global Age Related Macular Degeneration Drug Sales Share by Company (2015-2020)
Table 19. Global Age Related Macular Degeneration Drug Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Age Related Macular Degeneration Drug Revenue Share by Company (2015-2020)
Table 21. Global Age Related Macular Degeneration Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age Related Macular Degeneration Drug as of 2019)
Table 22. Global Age Related Macular Degeneration Drug Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Age Related Macular Degeneration Drug Manufacturing Sites and Area Served
Table 24. Manufacturers Age Related Macular Degeneration Drug Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Age Related Macular Degeneration Drug Players
Table 27. Global Age Related Macular Degeneration Drug Sales (K Units) by Type (2015-2020)
Table 28. Global Age Related Macular Degeneration Drug Sales Share by Type (2015-2020)
Table 29. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Age Related Macular Degeneration Drug Price (K Units) by Type (2015-2020)
Table 31. Global Age Related Macular Degeneration Drug Sales Share by Type (2021-2026)
Table 32. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Age Related Macular Degeneration Drug Revenue Share by Type (2021-2026)
Table 34. Global Age Related Macular Degeneration Drug Price (K Units) by Type (2021-2026)
Table 35. Global Age Related Macular Degeneration Drug Sales (K Units) by Application (2015-2020)
Table 36. Global Age Related Macular Degeneration Drug Sales Share by Application (2015-2020)
Table 37. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Age Related Macular Degeneration Drug Price (K Units) by Application (2015-2020)
Table 39. Global Age Related Macular Degeneration Drug Sales (K Units) by Application (2021-2026)
Table 40. Global Age Related Macular Degeneration Drug Sales Share by Application (2021-2026)
Table 41. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Age Related Macular Degeneration Drug Revenue Share by Application (2021-2026)
Table 43. Global Age Related Macular Degeneration Drug Price (K Units) by Application (2021-2026)
Table 44. United States Age Related Macular Degeneration Drug Sales (K Units) by Company (2015-2020)
Table 45. United States Age Related Macular Degeneration Drug Sales Market Share by Company (2015-2020)
Table 46. United States Age Related Macular Degeneration Drug Sales (K Units) by Type (2015-2020)
Table 47. United States Age Related Macular Degeneration Drug Sales Market Share by Type (2015-2020)
Table 48. United States Age Related Macular Degeneration Drug Sales (K Units) by Application (2015-2020)
Table 49. United States Age Related Macular Degeneration Drug Sales Market Share by Application (2015-2020)
Table 50. Europe Age Related Macular Degeneration Drug Sales (K Units) by Company (2015-2020)
Table 51. Europe Age Related Macular Degeneration Drug Sales Market Share by Company (2015-2020)
Table 52. Europe Age Related Macular Degeneration Drug Sales (K Units) by Type (2015-2020)
Table 53. Europe Age Related Macular Degeneration Drug Sales Market Share by Type (2015-2020)
Table 54. Europe Age Related Macular Degeneration Drug Sales (K Units) by Application (2015-2020)
Table 55. Europe Age Related Macular Degeneration Drug Sales Market Share by Type (2015-2020)
Table 56. China Age Related Macular Degeneration Drug Sales (K Units) by Company (2015-2020)
Table 57. China Age Related Macular Degeneration Drug Sales Market Share by Company (2015-2020)
Table 58. China Age Related Macular Degeneration Drug Sales (K Units) by Type (2015-2020)
Table 59. China Age Related Macular Degeneration Drug Sales Market Share by Type (2015-2020)
Table 60. China Age Related Macular Degeneration Drug Sales (K Units) by Application (2015-2020)
Table 61. China Age Related Macular Degeneration Drug Sales Market Share by Application (2015-2020)
Table 62. Japan Age Related Macular Degeneration Drug Sales (K Units) by Company (2015-2020)
Table 63. Japan Age Related Macular Degeneration Drug Sales Market Share by Company (2015-2020)
Table 64. Japan Age Related Macular Degeneration Drug Sales (K Units) by Type (2015-2020)
Table 65. Japan Age Related Macular Degeneration Drug Sales Market Share by Type (2015-2020)
Table 66. Japan Age Related Macular Degeneration Drug Sales (K Units) by Application (2015-2020)
Table 67. Japan Age Related Macular Degeneration Drug Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Age Related Macular Degeneration Drug Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Age Related Macular Degeneration Drug Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Age Related Macular Degeneration Drug Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Application (2015-2020)
Table 74. India Age Related Macular Degeneration Drug Sales (K Units) by Company (2015-2020)
Table 75. India Age Related Macular Degeneration Drug Sales Market Share by Company (2015-2020)
Table 76. India Age Related Macular Degeneration Drug Sales (K Units) by Type (2015-2020)
Table 77. India Age Related Macular Degeneration Drug Sales Market Share by Type (2015-2020)
Table 78. India Age Related Macular Degeneration Drug Sales (K Units) by Application (2015-2020)
Table 79. India Age Related Macular Degeneration Drug Sales Market Share by Application (2015-2020)
Table 80. Regeneron Pharmaceuticals Corporation Information
Table 81. Regeneron Pharmaceuticals Description and Business Overview
Table 82. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product
Table 84. Regeneron Pharmaceuticals Recent Development
Table 85. Bayer HealthCare Corporation Information
Table 86. Bayer HealthCare Description and Business Overview
Table 87. Bayer HealthCare Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Bayer HealthCare Age Related Macular Degeneration Drug Product
Table 89. Bayer HealthCare Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novartis Age Related Macular Degeneration Drug Product
Table 94. Novartis Recent Development
Table 95. Roche Corporation Information
Table 96. Roche Description and Business Overview
Table 97. Roche Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Roche Age Related Macular Degeneration Drug Product
Table 99. Roche Recent Development
Table . Kanghong Pharma Corporation Information
Table . Kanghong Pharma Description and Business Overview
Table . Kanghong Pharma Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Kanghong Pharma Age Related Macular Degeneration Drug Product
Table . Kanghong Pharma Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Age Related Macular Degeneration Drug Distributors List
Table 108. Age Related Macular Degeneration Drug Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Age Related Macular Degeneration Drug Product Picture
Figure 2. Global Age Related Macular Degeneration Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Age Related Macular Degeneration Drug Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Other Examples
Figure 9. Global Age Related Macular Degeneration Drug Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Age Related Macular Degeneration Drug Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Age Related Macular Degeneration Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Age Related Macular Degeneration Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Age Related Macular Degeneration Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Age Related Macular Degeneration Drug Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Age Related Macular Degeneration Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Age Related Macular Degeneration Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Age Related Macular Degeneration Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Age Related Macular Degeneration Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Age Related Macular Degeneration Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Age Related Macular Degeneration Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Age Related Macular Degeneration Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Age Related Macular Degeneration Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Age Related Macular Degeneration Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Age Related Macular Degeneration Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Age Related Macular Degeneration Drug Players Market Share by Revenue in Age Related Macular Degeneration Drug 2015 & 2019
Figure 27. Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Age Related Macular Degeneration Drug Revenue Share by Type (2015-2020)
Figure 29. Global Age Related Macular Degeneration Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Age Related Macular Degeneration Drug Revenue Share by Application (2015-2020)
Figure 31. Global Age Related Macular Degeneration Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Age Related Macular Degeneration Drug Sales Market Share by Type in 2019
Figure 33. United States Age Related Macular Degeneration Drug Sales Market Share by Type in 2019
Figure 34. Europe Age Related Macular Degeneration Drug Sales Market Share by Company in 2019
Figure 35. Europe Age Related Macular Degeneration Drug Sales Market Share by Type in 2019
Figure 36. Europe Age Related Macular Degeneration Drug Sales Market Share by Application in 2019
Figure 37. China Age Related Macular Degeneration Drug Sales Market Share by Company in 2019
Figure 38. China Age Related Macular Degeneration Drug Sales Market Share by Type in 2019
Figure 39. China Age Related Macular Degeneration Drug Sales Market Share by Application in 2019
Figure 40. Japan Age Related Macular Degeneration Drug Sales Market Share by Company in 2019
Figure 41. Japan Age Related Macular Degeneration Drug Sales Market Share by Type in 2019
Figure 42. Japan Age Related Macular Degeneration Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Application in 2019
Figure 46. India Age Related Macular Degeneration Drug Sales Market Share by Company in 2019
Figure 47. India Age Related Macular Degeneration Drug Sales Market Share by Type in 2019
Figure 48. India Age Related Macular Degeneration Drug Sales Market Share by Application in 2019
Figure 49. Regeneron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bayer HealthCare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Kanghong Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Key Raw Materials Price Trend
Figure 55. Manufacturing Cost Structure of Age Related Macular Degeneration Drug
Figure 56. Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure 57. Age Related Macular Degeneration Drug Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Porter's Five Forces Analysis
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
黄斑変性薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Macular Degeneration Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Macular Degenerati…- 黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx mil…
- 若年性黄斑変性症（シュタルガルト病）治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Juvenile Macular Degeneration (Stargardt Disease) Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx millio…
- 黄斑浮腫治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Macular Edema Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Macular Edema Ther…
- 象皮病薬の世界市場レポート2020 Market Analysis and Insights: Global Elephantiasis Drug Market The global Elephantiasis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Elephantiasis Drug Scope and Market Size The global Elephantias…